North America's Market Lead: Driving Glioma Treatment through High Awareness and Favorable Policies
The North America region holds the dominant share of the Global Glioma Diagnosis and Treatment Market, capturing 45.80% of the market in 2022. This leadership position is a result of several deeply entrenched structural advantages, rather than just a higher disease incidence. The U.S. and Canada benefit from a mature, highly sophisticated healthcare infrastructure that can support the complex,...
0 Reacties 0 aandelen 576 Views 0 voorbeeld
MTSocial https://mtsocial.ir